CLICK on the image to see it in a larger size
See more products at:
Description
Features
In depth analysis
NOBACCO CHROMA
The renewed line of NOBACCO Chroma eliquid adds color to our choices, making our everyday life even more delicious. It combines the highest quality ingredients with the most refreshing pleasure!
Research & development and Quality Assurance of each flavor formula is the result of the extensive research conducted by the Laboratory of Molecular Biology and Immunology (LMBI) of the Pharmaceutical Dept, Patras University, in the context of the strategic alliance with Aquarius Project from 2014 to 2019.
The laboratory’s group of researchers, with their high scientific training and experience, after many years of research, designed and developed recipes that provide the best possible vaping experience.
More specifically:
• All raw materials are selected according to the strictest criteria, making them suitable and safe for use with electronic cigarette.
• High Purity nicotine (99.9%).
• The product development process is following all safety standards and is carried out in an environment were all conditions are controlled.
• Inspection of the final product with modern and analytical validated methods, attesting to its quality and safety.
Chroma Line consists of more fruity and imaginative flavours, with 30% VG / 70% PG composition.
Chroma Line e-liquids are available in 4 different nicotine levels (0, 6, 12 and 18mg/ml).
In depth analysis
AQUARIUS PROJECT
Aquarius Project was established through the pioneer alliance of NOBACCO and LMBI (Laboratory of Molecular Biology and Immunology), Pharmaceutical Dept, Patras University.
NOBACCO’s partnership with the LMBI, Pharmaceutical Dept, Patras University is a pioneer initiative which puts the collaboration of the academic community with the private sector into practice, following the international trend to connect production with knowledge and innovation.
AQUARIUS PROJECT is the first company in Greece that emerged with the sole purpose of specializing in the production of e-liquids. All manufacturing procedures adhere to the strictest international standards.
The company’s driving force is the investment in the Greek research and innovation, such as the formation of the strategic alliance with the LMBI (Laboratory of Molecular Biology and Immunology), Pharmaceutical Dept, Patras University from 2014 to 2019.
Aquarius Project’s mission is to develop innovative products for millions of Electronic Nicotine Delivery Systems’ users (ENDS) in the world, abiding by the strictest international standards.
Its vision is to create a line of products that will gain the trust of vapers around the world, and will add value to the production and entrepreneurship of Greece.
NOBACCO’s partnership with the LMBI, Pharmaceutical Dept, Patras University is a pioneer initiative which puts the collaboration of the academic community with the private sector into practice, following the international trend to connect production with knowledge and innovation.
AQUARIUS PROJECT is the first company in Greece that emerged with the sole purpose of specializing in the production of e-liquids. All manufacturing procedures adhere to the strictest international standards.
The company’s driving force is the investment in the Greek research and innovation, such as the formation of the strategic alliance with the LMBI (Laboratory of Molecular Biology and Immunology), Pharmaceutical Dept, Patras University from 2014 to 2019.
Aquarius Project’s mission is to develop innovative products for millions of Electronic Nicotine Delivery Systems’ users (ENDS) in the world, abiding by the strictest international standards.
Its vision is to create a line of products that will gain the trust of vapers around the world, and will add value to the production and entrepreneurship of Greece.
In depth analysis
TPD COMPLIANT
Nobacco Chroma e-liquid series are fully harmonized with the EU (Tobacco Products Directive2014/40/EU).
They have been tested by analyses both in their liquid form (replenishment e-liquid) and in the inhalation vapor mixture released during use of the electronic cigarette.
They are governed by the European packaging specifications and all physicochemical and toxicological data (including toxicological analysis), have been communicated to the European Commission's Joint Entry Portal (EUCEG), the Ministry of Health, the General State Chemical Laboratory and the General Chemicals Registry. Are sold in a sealed pack of 10ml and feature a child-resistant safety cap (Child Proof).
They carry all mandatory warnings and markings in accordance with Regulation 1272/2008 (CLP) and European Directive 2014/40 / EU (TPD).
NOBACCO is one of the five electronic cigarette companies of the European Union, which was invited by the Commission, in 2015, to participate in shaping the regulatory framework for the New European Directive on Tobacco Products and Electronic Cigarettes.
They have been tested by analyses both in their liquid form (replenishment e-liquid) and in the inhalation vapor mixture released during use of the electronic cigarette.
They are governed by the European packaging specifications and all physicochemical and toxicological data (including toxicological analysis), have been communicated to the European Commission's Joint Entry Portal (EUCEG), the Ministry of Health, the General State Chemical Laboratory and the General Chemicals Registry. Are sold in a sealed pack of 10ml and feature a child-resistant safety cap (Child Proof).
They carry all mandatory warnings and markings in accordance with Regulation 1272/2008 (CLP) and European Directive 2014/40 / EU (TPD).
NOBACCO is one of the five electronic cigarette companies of the European Union, which was invited by the Commission, in 2015, to participate in shaping the regulatory framework for the New European Directive on Tobacco Products and Electronic Cigarettes.
Contents of Package
Features
In depth analysis
NOBACCO CHROMA
The renewed line of NOBACCO Chroma eliquid adds color to our choices, making our everyday life even more delicious. It combines the highest quality ingredients with the most refreshing pleasure!
Research & development and Quality Assurance of each flavor formula is the result of the extensive research conducted by the Laboratory of Molecular Biology and Immunology (LMBI) of the Pharmaceutical Dept, Patras University, in the context of the strategic alliance with Aquarius Project from 2014 to 2019.
The laboratory’s group of researchers, with their high scientific training and experience, after many years of research, designed and developed recipes that provide the best possible vaping experience.
More specifically:
• All raw materials are selected according to the strictest criteria, making them suitable and safe for use with electronic cigarette.
• High Purity nicotine (99.9%).
• The product development process is following all safety standards and is carried out in an environment were all conditions are controlled.
• Inspection of the final product with modern and analytical validated methods, attesting to its quality and safety.
Chroma Line consists of more fruity and imaginative flavours, with 30% VG / 70% PG composition.
Chroma Line e-liquids are available in 4 different nicotine levels (0, 6, 12 and 18mg/ml).
In depth analysis
AQUARIUS PROJECT
Aquarius Project was established through the pioneer alliance of NOBACCO and LMBI (Laboratory of Molecular Biology and Immunology), Pharmaceutical Dept, Patras University.
NOBACCO’s partnership with the LMBI, Pharmaceutical Dept, Patras University is a pioneer initiative which puts the collaboration of the academic community with the private sector into practice, following the international trend to connect production with knowledge and innovation.
AQUARIUS PROJECT is the first company in Greece that emerged with the sole purpose of specializing in the production of e-liquids. All manufacturing procedures adhere to the strictest international standards.
The company’s driving force is the investment in the Greek research and innovation, such as the formation of the strategic alliance with the LMBI (Laboratory of Molecular Biology and Immunology), Pharmaceutical Dept, Patras University from 2014 to 2019.
Aquarius Project’s mission is to develop innovative products for millions of Electronic Nicotine Delivery Systems’ users (ENDS) in the world, abiding by the strictest international standards.
Its vision is to create a line of products that will gain the trust of vapers around the world, and will add value to the production and entrepreneurship of Greece.
NOBACCO’s partnership with the LMBI, Pharmaceutical Dept, Patras University is a pioneer initiative which puts the collaboration of the academic community with the private sector into practice, following the international trend to connect production with knowledge and innovation.
AQUARIUS PROJECT is the first company in Greece that emerged with the sole purpose of specializing in the production of e-liquids. All manufacturing procedures adhere to the strictest international standards.
The company’s driving force is the investment in the Greek research and innovation, such as the formation of the strategic alliance with the LMBI (Laboratory of Molecular Biology and Immunology), Pharmaceutical Dept, Patras University from 2014 to 2019.
Aquarius Project’s mission is to develop innovative products for millions of Electronic Nicotine Delivery Systems’ users (ENDS) in the world, abiding by the strictest international standards.
Its vision is to create a line of products that will gain the trust of vapers around the world, and will add value to the production and entrepreneurship of Greece.
In depth analysis
TPD COMPLIANT
Nobacco Chroma e-liquid series are fully harmonized with the EU (Tobacco Products Directive2014/40/EU).
They have been tested by analyses both in their liquid form (replenishment e-liquid) and in the inhalation vapor mixture released during use of the electronic cigarette.
They are governed by the European packaging specifications and all physicochemical and toxicological data (including toxicological analysis), have been communicated to the European Commission's Joint Entry Portal (EUCEG), the Ministry of Health, the General State Chemical Laboratory and the General Chemicals Registry. Are sold in a sealed pack of 10ml and feature a child-resistant safety cap (Child Proof).
They carry all mandatory warnings and markings in accordance with Regulation 1272/2008 (CLP) and European Directive 2014/40 / EU (TPD).
NOBACCO is one of the five electronic cigarette companies of the European Union, which was invited by the Commission, in 2015, to participate in shaping the regulatory framework for the New European Directive on Tobacco Products and Electronic Cigarettes.
They have been tested by analyses both in their liquid form (replenishment e-liquid) and in the inhalation vapor mixture released during use of the electronic cigarette.
They are governed by the European packaging specifications and all physicochemical and toxicological data (including toxicological analysis), have been communicated to the European Commission's Joint Entry Portal (EUCEG), the Ministry of Health, the General State Chemical Laboratory and the General Chemicals Registry. Are sold in a sealed pack of 10ml and feature a child-resistant safety cap (Child Proof).
They carry all mandatory warnings and markings in accordance with Regulation 1272/2008 (CLP) and European Directive 2014/40 / EU (TPD).
NOBACCO is one of the five electronic cigarette companies of the European Union, which was invited by the Commission, in 2015, to participate in shaping the regulatory framework for the New European Directive on Tobacco Products and Electronic Cigarettes.
Similar products
Follow us on Social Media
This site contains potentially reduced risk products that may be harmful to health and is intended for adult smokers only. Purchase and use by persons under the age of 18 is prohibited. NOBACCO products containing nicotine, which is a highly addictive substance, are not suitable for use by: Persons under the age of 18, pregnant or breastfeeding persons, persons who are sensitive or allergic to nicotine and they are not recommended for use by people with heart disease or hypertension. Keep away from children.
No. ESA Register: 119582601000
